YTHDF2 stabilizes the CX3CL1 transcript in an manner dependent on m6A, modulating the interaction between CD8 T cells and thereby promoting treatment-induced anti-tumor immune responses in the liver [46]. This evidence concerns the gene CX3CL1 and neoplasm.